Catalyst Wire Dossier Catalyst Wire Dossier

Oxybutynin topical gel 3%

oxybutynin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxybutynin topical gel 3%, covering 2018-06-19 to 2018-06-19. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults [NA]

See pricing